Cargando…
Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
Tachyarrhythmias are common complications of critically ill patients treated on intensive care units. Landiolol is an ultra-short acting beta-blocker with a very high beta1-selectivity. Therefore, landiolol effectively reduces heart rate with only minimal negative effects on blood pressure and inotr...
Autores principales: | Gangl, Clemens, Krychtiuk, Konstantin A, Schoenbauer, Robert, Speidl, Walter S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190750/ https://www.ncbi.nlm.nih.gov/pubmed/35706896 http://dx.doi.org/10.1093/eurheartjsupp/suac026 |
Ejemplares similares
-
Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure
por: Shiga, Tsuyoshi
Publicado: (2022) -
The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
por: Bezati, Sofia, et al.
Publicado: (2022) -
Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy
por: Dan, Gheorghe-Andrei
Publicado: (2022) -
Acute rate control in atrial fibrillation: an urgent need for the clinician
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2022) -
Short acting intravenous beta-blocker as a first line of treatment for atrial fibrillation after cardiac surgery: a prospective observational study
por: Chapalain, X, et al.
Publicado: (2022)